Cargando…
Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis
Dysregulation of inflammation is hypothesized to play a crucial role in the severe complications of COVID-19, with the IL-1/IL-6 pathway being central. Here, we report on the treatment of eight severe COVID-19 pneumonia patients—seven hospitalized in intensive care units (ICUs) in Greece and one non...
Autores principales: | Dimopoulos, George, de Mast, Quirijn, Markou, Nikolaos, Theodorakopoulou, Maria, Komnos, Apostolos, Mouktaroudi, Maria, Netea, Mihai G., Spyridopoulos, Themistoklis, Verheggen, Rebecca J., Hoogerwerf, Jacobien, Lachana, Alexandra, van de Veerdonk, Frank L., Giamarellos-Bourboulis, Evangelos J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221383/ https://www.ncbi.nlm.nih.gov/pubmed/32411313 http://dx.doi.org/10.1016/j.chom.2020.05.007 |
Ejemplares similares
-
Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases
por: Baverez, Clara, et al.
Publicado: (2022) -
Ebola Virus Disease has Features of Hemophagocytic Lymphohistiocytosis Syndrome
por: van der Ven, Andre J. A. M., et al.
Publicado: (2015) -
Successful treatment of cytomegalovirus associated hemophagocytic lymphohistiocytosis with the interleukin 1 inhibitor – anakinra
por: Divithotawela, Chandima, et al.
Publicado: (2015) -
PB2045: USE OF ANAKINRA IN THE TREATMENT OF ADULT HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: A SYSTEMATIC REVIEW
por: Eshaghpour, Ali, et al.
Publicado: (2023) -
Favorable outcomes following allogeneic transplantation in adults with hemophagocytic lymphohistiocytosis
por: Gooptu, Mahasweta, et al.
Publicado: (2022)